MedPath

Assessment of the glycemic responses to nutritional products

Completed
Conditions
niet van toepassing
10018424
Registration Number
NL-OMON49247
Lead Sponsor
utricia Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
10
Inclusion Criteria

1. Age * 18 and * 60 years
2. Body Mass Index (BMI) * 18.5 and * 24.9 kg/m2
3. Written informed consent
4. Willingness and ability to comply with the protocol
5. Judged by the investigator to be in good health

Exclusion Criteria

1. Known Diabetes Mellitus type I or type II, rebound hypoglycemia and/or any
other medical condition that interferes with glucose metabolism
2. Any use of anticoagulants, steroids, protease inhibitors or antipsychotics
and/or any medication known to affect glucose tolerance and/or to influence
digestion and absorption of nutrients within 1 week of screening, in opinion of
the investigator
3. Any known disease which influence digestion and absorption of nutrients
within 1 week of screening
4. Any known food allergy or intolerance
5. Adherence to a strict vegan diet and/or a weight loss program
6. Any known bleeding disorder

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>GI = Capillary blood glucose iAUC0-120 [mmol/l] of test product/ mean capillary<br /><br>blood glucose iAUC0-120 [mmol/l] of reference product</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>- GL=GI*available carbohydrate/given amount<br /><br>- Capillary blood glucose mmol/l and iAUC0-120 [mmol/l*min] of the reference<br /><br>product and test product(s)<br /><br>- Capillary blood glucose iCmax [mmol/l] and Tmax [min] of the reference<br /><br>product and test product(s)<br /><br>- Appetite profile and liking of the test product using visual analogue scales </p><br>
© Copyright 2025. All Rights Reserved by MedPath